Cargando…

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor

The expression of p53 protein was examined in a series of 111 colorectal cancer adenocarcinomas with a long follow-up. A quantitative luminometric immunoassay (LIA) was used for the measurement of wild-type and mutant p53 protein in extracts from colorectal tumour cytosols, p53 being detected in 42%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adrover, E, Maestro, M L, Sanz-Casla, M T, Barco, V del, Cerdán, J, Fernández, C, Balibrea, J L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374355/ https://www.ncbi.nlm.nih.gov/pubmed/10487622 http://dx.doi.org/10.1038/sj.bjc.6690660

Ejemplares similares

Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study
por: Holli, K, et al.
Publicado: (2001)

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
por: Vermeulen, P B, et al.
Publicado: (1999)

Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
por: Wong, N A C S, et al.
Publicado: (2001)

Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
por: Gordziel, C, et al.
Publicado: (2013)

A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients
por: Huuhtanen, R L, et al.
Publicado: (1999)

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
por: Paradiso, A, et al.
Publicado: (2000)

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis
por: Ropponen, K M, et al.
Publicado: (1999)

Growth dysregulation and p53 accumulation in human primary colorectal cancer
por: Watson, D S, et al.
Publicado: (1999)

Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis
por: Maehara, Y, et al.
Publicado: (1999)

Absence of p53 in Clara cells favours multinucleation and loss of cell cycle arrest
por: Armit, Christopher J, et al.
Publicado: (2002)

Favourable outcomes of a preventive screening and counselling programme for older people in underprivileged areas in the Netherlands: The PRIMUS project
por: van Dijk, D.J. Annemarie, et al.
Publicado: (2017)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients
por: Scorilas, A, et al.
Publicado: (2001)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

Atopy--a favourable prognostic factor for survival in Hodgkin's disease.
por: Amlot, P. L., et al.
Publicado: (1983)

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.
por: Starzynska, T., et al.
Publicado: (1992)

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status
por: Bras-Gonçalves, R A, et al.
Publicado: (2000)

Proteolytic cleavage of p53 mutants in response to mismatched DNA
por: Mee, T, et al.
Publicado: (1999)

Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000)

P53 germline mutations in childhood cancers and cancer risk for carrier individuals
por: Chompret, A, et al.
Publicado: (2000)

p53 in colorectal cancer: clinicopathological correlation and prognostic significance.
por: Scott, N., et al.
Publicado: (1991)

p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas
por: Mousses, S, et al.
Publicado: (2001)

High‐fibre enteral feeding results in improved anthropometrics and favourable gastrointestinal tolerance in malnourished children with growth failure
por: Kansu, Aydan, et al.
Publicado: (2018)

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999)

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Comparative study of preterm infants fed new and existing human milk fortifiers showed favourable markers of gastrointestinal status
por: Rigo, Jacques, et al.
Publicado: (2019)

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status
por: Mirjolet, J-F, et al.
Publicado: (2000)

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
por: Tollenaar, R. A., et al.
Publicado: (1998)

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line
por: Badie, C, et al.
Publicado: (2000)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes
por: Delia, D, et al.
Publicado: (2000)

Selective in vitro cytotoxicity effect of Drimia calcarata bulb extracts against p53 mutant HT-29 and p53 wild-type Caco-2 colorectal cancer cells through STAT5B regulation
por: Laka, K., et al.
Publicado: (2021)

In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases
por: Emanuels, A G, et al.
Publicado: (1999)

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67
por: Tut, V M, et al.
Publicado: (2001)

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
por: Veldhoen, N, et al.
Publicado: (1999)

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
por: Anttila, M A, et al.
Publicado: (1999)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.
por: Vega, F. J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_bacofds59phll3f8vcgk9lcqm2